Manjinder S. Lall
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Manjinder S. Lall.
Bioorganic & Medicinal Chemistry Letters | 2009
Jeremy T. Starr; Richard John Sciotti; Debra Hanna; Michael D. Huband; Lisa Mullins; Hongliang Cai; Jeffrey W. Gage; Mandy Lockard; Mark R. Rauckhorst; Robert M. Owen; Manjinder S. Lall; Mark Tomilo; Huifen Chen; Sandra P. McCurdy; Michael R. Barbachyn
Dual inhibitors of bacterial gyrB and parE based on a 5-(2-pyrimidinyl)-imidazo[1,2-a]pyridine template exhibited MICs (microg/mL) of 0.06-64 (Sau), 0.25-64 (MRSA), 0.06-64 (Spy), 0.06-64 (Spn), and 0.03-64 (FQR Spn). Selected examples were efficacious in mouse sepsis and lung infection models at <50mg/kg (PO dosing).
ACS Medicinal Chemistry Letters | 2011
Mark Edward Flanagan; Steven J. Brickner; Manjinder S. Lall; Jeffrey M. Casavant; Laura Deschenes; Steven M. Finegan; David M. George; Karl Granskog; Joel R. Hardink; Michael D. Huband; Thuy Hoang; Lucinda Lamb; Andrea Marra; Mark J. Mitton-Fry; John P. Mueller; Lisa Mullins; Mark C. Noe; John P. O'Donnell; David Pattavina; Joseph Penzien; Brandon P. Schuff; Jianmin Sun; David A. Whipple; Jennifer A. Young; Thomas D. Gootz
A novel series of monocarbam compounds exhibiting promising antibacterial activity against multidrug resistant Gram-negative microorganisms is reported, along with the synthesis of one such molecule MC-1 (1). Also reported are structure-activity relationships associated with the in vitro and in vivo efficacy of 1 and related analogues in addition to the hydrolytic stability of such compounds and possible implications thereof.
Journal of Medicinal Chemistry | 2013
Matthew Frank Brown; Mark J. Mitton-Fry; Rose Barham; Jeffrey M. Casavant; Brian S. Gerstenberger; Seungil Han; Joel R. Hardink; Thomas M. Harris; Thuy Hoang; Michael D. Huband; Manjinder S. Lall; M. Megan Lemmon; Chao Li; Jian Lin; Sandra P. McCurdy; Eric McElroy; Craig J. McPherson; Eric S. Marr; John P. Mueller; Lisa Mullins; Antonia A. Nikitenko; Mark C. Noe; Joseph Penzien; Mark Stephen Plummer; Brandon P. Schuff; Veerabahu Shanmugasundaram; Jeremy T. Starr; Jianmin Sun; Andrew P. Tomaras; Jennifer A. Young
Herein we describe the structure-aided design and synthesis of a series of pyridone-conjugated monobactam analogues with in vitro antibacterial activity against clinically relevant Gram-negative species including Pseudomonas aeruginosa , Klebsiella pneumoniae , and Escherichia coli . Rat pharmacokinetic studies with compound 17 demonstrate low clearance and low plasma protein binding. In addition, evidence is provided for a number of analogues suggesting that the siderophore receptors PiuA and PirA play a role in drug uptake in P. aeruginosa strain PAO1.
Chemical Biology & Drug Design | 2010
J. Richard Miller; Venkataraman Thanabal; Michael Melnick; Manjinder S. Lall; Charles Francis Donovan; Ronald W. Sarver; Doh-Yeel Lee; Jeff Ohren; Don Emerson
High‐throughput screening is utilized by pharmaceutical researchers and, increasingly, academic investigators to identify agents that act upon enzymes, receptors, and cellular processes. Screening hits include molecules that specifically bind the target and a greater number of non‐specific compounds. It is necessary to ‘triage’ these hits to identify the subset worthy of further exploration. As part of our antibacterial drug discovery effort, we applied a suite of biochemical and biophysical tools to accelerate the triage process. We describe application of these tools to a series of 9‐oxo‐4,9‐dihydropyrazolo[5,1‐b]quinazoline‐2‐carboxylic acids (PQ) hits from a screen of Escherichia coli phosphopantetheine adenylyltransferase (PPAT). Initial confirmation of specific binding to phosphopantetheine adenylyltransferase was obtained using biochemical and biophysical tools, including a novel orthogonal assay, isothermal titration calorimetry, and saturation transfer difference NMR. To identify the phosphopantetheine adenylyltransferase sub‐site bound by these inhibitors, two techniques were utilized: steady‐state enzyme kinetics and a novel 19F NMR method in which fluorine‐containing fragments that bind the ATP and/or phosphopantetheine sites serve as competitive reporter probes. These data are consistent with PQs binding the ATP sub‐site. In addition to identification of a series of PPAT inhibitors, the described hit triage process is broadly applicable to other enzyme targets in which milligram quantities of purified target protein are available.
Bioorganic & Medicinal Chemistry Letters | 2012
Mark J. Mitton-Fry; Matthew Frank Brown; Jeffrey M. Casavant; Steven M. Finegan; Mark Edward Flanagan; Hongying Gao; David M. George; Brian S. Gerstenberger; Seungil Han; Joel R. Hardink; Thomas M. Harris; Thuy Hoang; Michael D. Huband; Rebecca Irvine; Manjinder S. Lall; M. Megan Lemmon; Chao Li; Jian Lin; Sandra P. McCurdy; John P. Mueller; Lisa Mullins; Mark Niosi; Mark C. Noe; David Pattavina; Joseph Penzien; Mark Stephen Plummer; Hud Risley; Brandon P. Schuff; Veerabahu Shanmugasundaram; Jeremy T. Starr
Novel siderophore-linked monobactams with in vitro and in vivo anti-microbial activity against MDR Gram-negative pathogens are described.
Magnetic Resonance in Chemistry | 2017
Kathleen A. Farley; Usa Reilly; Dennis P. Anderson; Brian P. Boscoe; Mark W. Bundesmann; David A. Foley; Manjinder S. Lall; Chao Li; Matthew R. Reese; Jiangli Yan
In situ reaction monitoring tools offer the ability to track the progress of a synthetic reaction in real time to facilitate reaction optimization and provide kinetic/mechanistic insight. Herein, we report the utilization of flow NMR, flow IR, and other off‐line spectroscopy tools to monitor the progress of a flow chemistry reaction. The on‐line and off‐line tools were selected to facilitate the stereoselective kinetic resolution of a key racemic monomer, which lacked a chromophore, making conventional reaction monitoring difficult. Copyright
Tetrahedron | 2010
Xiangbing Qi; Grant T. Rice; Manjinder S. Lall; Mark Stephen Plummer; M. Christina White
Bioorganic & Medicinal Chemistry Letters | 2007
Frederick E. Boyer; J.V.N. Vara Prasad; Allison L. Choy; Louis Stanley Chupak; Michael R. Dermyer; Qizhu Ding; Michael D. Huband; Wenhua Jiao; Takushi Kaneko; Vladimir Khlebnikov; Ji-Young Kim; Manjinder S. Lall; Samarendra N. Maiti; Karina Romero; Xiujuan Wu
Archive | 2009
Matthew Frank Brown; Charles Francis Donovan; Edmund L. Ellsworth; Denton Wade Hoyer; Timothy Allen Johnson; Manjinder S. Lall; Chris Limberakis; Sean T. Murphy; Debra Ann Sherry; Clarke B. Taylor; Joseph Scott Warmus
Journal of Organic Chemistry | 2012
Manjinder S. Lall; Garrett Hoge; Tuan P. Tran; William Kissel; Sean Timothy Murphy; Clarke B. Taylor; Kim Marie Hutchings; Brian Samas; Edmund L. Ellsworth; Timothy Curran; H. D. Hollis Showalter